Biosolar cells: moving forward step by step
Through biosolar cells, researchers try to improve photosynthesis, the process through which plants, algae and some bacteria capture sunlight. The product of such ‘artificial leaves’ is hydrogen for instance, that can be processed to fuels and chemicals, with CO2 and nitrogen. There are many research programs in the area of direct conversion of sunlight, and
Lost in translation: Calls for Proposals are determined by language
The Bio-Based Industries Joint Undertaking, abbreviated as BBI JU, is in the final stages of the procedure to award funding for new research and development proposals. BBI JU is a €3.7 billion Public-Private Partnership between the EU and the Bio-based Industries Consortium. I participated in the evaluation of the 144 proposals that were submitted in
Séralini disproven – what will the EU do now?
Anyone who opposes genetically modified (GM) food can tell you that ‘in France’ they found that GM maize causes cancer in rats. This study was conducted under leadership of Gilles-Éric Séralini, professor in molecular biology at the University of Caen. His results, published in 2012, caused an upheaval. They stopped short the very gradual change
Rejuvenation through biotechnology, for whom?
In the entire discussion on biotechnological rejuvenation, very few researchers ask the question why this should be a goal worth pursuing. In a series of articles (July 25, July 28 and July 31) we explore the potential of biotechnology to prevent aging. And its personal and social implications. Deathless aging We return to the observation
The bioscience of immortality
Biotechnology has now reached the point that some researchers target rejuvenation as their goal, ultimately in humans. With a slight hint of immortality behind the horizon. But if we look more carefully, they are still far removed from those targets. Which will not hold back some wealthy senior citizens, fearing decline, to donate large sums
Healthy aging and the science of living forever
What will come after healthy aging? In biotechnology, advances have been so swift over the past few decades, that some scientists have started thinking of ways to tackle aging itself, that ultimate and fatal disease of mankind. Even with some hints that death may not be unavoidable any more – according to some researchers. ‘Deathless
Can we engineer life? 2.2 Development of recombinant-DNA technology
In 1973, Stanley Cohen and Herbert Boyer of Stanford University and University of California, did the first successful recombinant-DNA experiments on the bacterium Escherichia coli. Through genetic ‘cutting and pasting’ they succeeded in introducing resistance in this bacterium that inhabits our guts, to two antibiotics, tetracycline and kanamycine. Hans Tramper is professor emeritus in Bioprocess
New Call for Proposals issued by BBI JU
The Bio-based Industries Joint Undertaking, BBI JU, one of seven JUs under the Horizon2020 program, recently published their next Call for Proposals, the sixth one on the path towards 2020. At an info day in Brussels, visited by over 600 attendees, the organization presented and explained its latest Call. Under the influence of results from
on: 19 May 2019